Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream

被引：45

作者：

Chapman, MS ^{[1
]}

Spencer, SK ^{[1
]}

Brennick, JB ^{[1
]}

机构：

[1] Dartmouth Coll, Hitchcock Med Ctr, Dermatol Sect, Lebanon, NH 03756 USA

来源：

ARCHIVES OF DERMATOLOGY | 2003年 / 139卷 / 07期

关键词：

D O I：

10.1001/archderm.139.7.943

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：943 / 944

页数：2

共 5 条

[1] Imiquimod: a novel treatment for lentigo maligna [J].

Ahmed, I ;

Berth-Jones, J .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (04) :843-845

[2] Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream [J].

Beutner, KR ;

Geisse, JK ;

Helman, D ;

Fox, TL ;

Ginkel, A ;

Owens, ML .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (06) :1002-1007

[3] Interferon alfa-2a for melanoma metastases [J].

Kirkwood, JM ;

Ibrahim, JG ;

Sondak, VK ;

Ernstoff, MS ;

Ross, M .

LANCET, 2002, 359 (9310) :978-979

[4] Topical imiquimod treatment of a cutaneous melanoma metastasis [J].

Steinmann, A ;

Funk, JO ;

Schuler, G ;

von den Driesch, P .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (03) :555-556

[5] Immune-response modifiers: A new paradigm in the treatment of human papillomavirus [J].

Tyring, SK .

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (09) :584-596

← 1 →